Daniel Wolle

Stock Analyst at JP Morgan

(n/a)

# 4,322

Out of 4,670 analysts

3

Total ratings

n/a

Success rate

-39.16%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Daniel Wolle

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ITOS iTeos Therapeutics	Maintains: Overweight	$32 → $29	$8.32	+248.56%	2	Nov 13, 2023
	CARA Cara Therapeutics	Maintains: Overweight	$19 → $16	$0.31	+5,144.18%	1	Mar 7, 2023

iTeos Therapeutics

Nov 13, 2023

Maintains: Overweight

Price Target: $32 → $29

Current: $8.32

Upside: +248.56%

Cara Therapeutics

Mar 7, 2023

Maintains: Overweight

Price Target: $19 → $16

Current: $0.31

Upside: +5,144.18%